IRIS
MARZIONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.614
EU - Europa 3.468
AS - Asia 1.414
SA - Sud America 203
AF - Africa 100
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
Totale 11.810
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.594
UA - Ucraina 660
IT - Italia 511
RU - Federazione Russa 456
IE - Irlanda 448
SG - Singapore 413
SE - Svezia 391
CN - Cina 362
DE - Germania 318
HK - Hong Kong 285
DK - Danimarca 228
BR - Brasile 195
TR - Turchia 176
FI - Finlandia 137
GB - Regno Unito 134
KR - Corea 116
FR - Francia 109
CI - Costa d'Avorio 50
MA - Marocco 41
IN - India 24
BE - Belgio 23
CA - Canada 14
NL - Olanda 13
AT - Austria 12
JP - Giappone 9
PL - Polonia 9
EU - Europa 6
EG - Egitto 5
RO - Romania 5
IR - Iran 4
MX - Messico 4
RS - Serbia 4
UZ - Uzbekistan 4
BD - Bangladesh 3
IQ - Iraq 3
PK - Pakistan 3
PY - Paraguay 3
AR - Argentina 2
AZ - Azerbaigian 2
CH - Svizzera 2
CO - Colombia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
TN - Tunisia 2
TW - Taiwan 2
A1 - Anonimo 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CU - Cuba 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
GA - Gabon 1
HN - Honduras 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MK - Macedonia 1
MN - Mongolia 1
OM - Oman 1
PT - Portogallo 1
VN - Vietnam 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 11.810
Salva come PNG Salva come JPEG
Città #
Chandler 785
Jacksonville 711
Fairfield 605
Dublin 447
Ashburn 438
Des Moines 427
Boardman 391
Hong Kong 284
Woodbridge 283
Wilmington 274
Houston 255
Seattle 222
Cambridge 211
New York 209
Centro 202
Singapore 180
Lawrence 163
Princeton 163
San Mateo 151
The Dalles 126
Ann Arbor 125
Moscow 90
San Diego 83
Washington 56
Abidjan 50
Beijing 44
London 38
Guangzhou 36
Ancona 34
Turin 31
Shanghai 30
Los Angeles 29
Helsinki 24
Wuhan 23
Nuremberg 21
Brussels 17
Norwalk 17
Marche 16
Pune 16
Wuxi 14
Dallas 13
São Paulo 13
Jiaxing 12
Torre Annunziata 10
Kilburn 9
Izmir 8
Ottawa 8
Perugia 8
Falls Church 7
Antwerp 6
Appignano 6
Aversa 6
Civitanova Marche 6
Milan 6
New Bedfont 6
Redmond 6
Rio de Janeiro 6
Senigallia 6
Vienna 6
Andover 5
Brasília 5
Chicago 5
Fayetteville 5
Quanzhou 5
Santa Clara 5
Belgrade 4
Florence 4
Florianópolis 4
Frankfurt am Main 4
Jinhua 4
Naaldwijk 4
Nanjing 4
Padova 4
Palermo 4
Porto 4
Rome 4
Shaoxing 4
Shenzhen 4
Southend 4
Squinzano 4
Toronto 4
Acton 3
Baghdad 3
Bari 3
Belo Horizonte 3
Cairo 3
Chiswick 3
Council Bluffs 3
Edinburgh 3
Falerone 3
Itajaí 3
Jesi 3
Jinan 3
Lunano 3
Munich 3
Naples 3
Prescot 3
Redwood City 3
Seoul 3
Southwark 3
Totale 7.620
Salva come PNG Salva come JPEG
Nome #
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 147
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. 124
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 124
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 112
Increased local dopamine secretion has growth promoting effects in cholangiocarcinoma. 108
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 108
Descriptive epidemiology of cholangiocarcinoma in Italy. 107
Hepatitis E in a region of Italy: An emerging autochthonous infection? 105
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 103
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 101
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 101
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 100
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models 100
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. 99
Clinical implications of novel aspects of biliary pathophysiology. 98
Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes 97
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 97
Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms. 96
Administration of r-VEGF-A prevents hepatic artery ligation induced bile duct damage in bile duct ligated rats. 95
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 95
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 95
Cholangiocarcinoma development: the resurgence of bile acids 95
Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. 94
Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology 94
Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals 94
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway 93
Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 93
Leptin enhances cholangiocarcinoma cell growth. 91
Aging and the Biological Response to Liver Injury 91
Bile acid depletion and repletion regulate cholangiocyte proliferation and secretion in bile duct ligated rats through a phosphatidylinositol 3-kinase-dependent pathway. 90
Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. 90
Functional and Structural Features of Cholangiocytes in Health and Disease 90
Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database 89
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis 88
Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies 88
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions 88
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 88
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 87
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 87
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma 86
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 86
Exendin-4, a Glucagon-Like Peptide 1 receptor agonist, protects cholangiocytes from apoptosis 84
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 84
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 84
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 84
Role of apoptosis in development of primary biliary cirrhosis 83
Current targets for Primary Sclerosing cholangitis 83
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 83
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 83
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies 82
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 82
Functional heterogeneity of the intrahepatic biliary tree 81
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 81
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 81
Selective Na+/H+ inhibition by cariporide reduces liver fibrosis in the rat 79
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 79
Development and functional characterization of extrahepatic cholangiocyte lines from normal rats 79
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 78
Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 78
Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology 77
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct ligated rats 76
Bullous pemphigoid of Lever and celiac disease: a coincidental occurrence or an unusual association? 76
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 75
Role of cholangiocytes in primary biliary cirrhosis 75
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 74
CAMP STIMULATES THE SECRETORY AND PROLIFERATIVE CAPACITY OF THE RAT BILIARY EPITHELIUM THROUGH CHANGES IN THE PKA/SRC/MEK/ERK1/2 PATHWAY 74
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 74
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. 73
The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice 73
Current and novel therapeutic opportunities for systemic therapy in biliary cancer 73
Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver 72
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells 72
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 72
Cholangiocytes in health and disease: From basic science to novel treatments 72
NUOVA METODICA DIAGNOSTICA PER LE NEOPLASIE DEL PANCREAS 71
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 71
Small Mouse cholangiocytes proliferate in response to H1 Histamine receptor stimulation by activation of the IP3/CAMK I/CREB pathway. 70
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic Acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts 70
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo. 70
Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases 70
Autocrine Regulation of Biliary Pathology by Activated Cholangiocytes. 69
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 69
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 69
Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances 69
Endogenous opioid peptides and chronic liver disease: from bedside to bench. 68
Alpha-1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca(2+)- and PKC-dependent stimulation of cAMP 68
The significance of genetics for cholangiocarcinoma development 68
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 68
Primary Biliary Cholangitis: advances in management and treatment of the disease 68
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 68
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. 67
Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt 67
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis 67
Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases 67
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 67
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte proliferation and secretion of bile duct ligated rats through activation of PKC alpha. 66
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls 65
Knockout of the primary sclerosing cholangitis-risk gene Fut2 causes liver disease in mice 65
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 64
Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice 64
Totale 8.355
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.257
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020276 0 0 0 0 0 0 0 0 0 0 57 219
2020/20212.374 129 250 303 63 283 142 186 189 208 244 229 148
2021/20221.384 72 356 19 37 15 68 80 85 68 100 223 261
2022/20232.548 215 204 144 196 158 623 4 165 616 13 161 49
2023/20241.542 254 34 118 306 245 328 16 29 11 28 10 163
2024/20252.223 328 282 107 46 88 115 161 98 714 208 76 0
Totale 12.216